However, although ZFHX4 mutations were observed in eight ESCC patients in the TCGA datasets, there was no correlation between ZFHX4 mutations and survival of ESCC patients, EAD (Supplementary Fig. 2C) and the remaining cancer types (Supplementary Table 1). This evidence concerns the gene ZFHX4 and esophageal squamous cell carcinoma.